Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Paul Gaynon
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Disorders
Living Beings
Procedures
Concepts & Ideas
Phenomena
Chemicals & Drugs
Anatomy
Sign-in to see full Profile
Network (preview)
69
Sather, Harland
50
Steinherz, Peter
39
Uckun, Fatih
36
Nachman, James
31
Trigg, Michael
31
Sensel, Martha
29
Heerema, Nyla
26
Reaman, Gregory
20
Bostrom, Bruce
19
Hutchinson, Raymond
14
Lange, Beverly
12
Bleyer, Archie
10
La, Mei
10
Seibel, Nita
10
Tubergen, DG
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Paul Gaynon (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Nachman James B; La Mei K; Hunger Stephen P; Heerema Nyla A; Gaynon Paul S; Hastings Caroline; Mattano Leonard A; Sather Harland; Devidas Meenakshi; Freyer David R; Steinherz Peter G; Seibel Nita L
Young adults with acute lymphoblastic leukemia have an excellent outcome with chemotherapy alone and benefit from intensive postinduction treatment: a report from the children's oncology group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5189-94.
-
2009: Schultz Kirk R; Bowman W Paul; Aledo Alexander; Slayton William B; Sather Harland; Devidas Meenakshi; Wang Chenguang; Davies Stella M; Gaynon Paul S; Trigg Michael; Rutledge Robert; Burden Laura; Jorstad Dean; Carroll Andrew; Heerema Nyla A; Winick Naomi; Borowitz Michael J; Hunger Stephen P; Carroll William L; Camitta Bruce
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(31):5175-81.
-
2009: Jeha Sima; Razzouk Bassem; Rytting Michael; Rheingold Susan; Albano Edythe; Kadota Richard; Luchtman-Jones Lori; Bomgaars Lisa; Gaynon Paul; Goldman Stewart; Ritchey Kim; Arceci Robert; Altman Arnold; Stine Kimo; Steinherz Laurel; Steinherz Peter
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(26):4392-7.
-
2009: Sposto Richard; Gaynon Paul S
An adjustment for patient heterogeneity in the design of two-stage phase II trials.
Statistics in medicine 2009;28(20):2566-79.
-
2008: Stock Wendy; La Mei; Sanford Ben; Bloomfield Clara D; Vardiman James W; Gaynon Paul; Larson Richard A; Nachman James;
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies.
Blood 2008;112(5):1646-54.
-
2008: Raetz Elizabeth A; Borowitz Michael J; Devidas Meenakshi; Linda Stephen B; Hunger Stephen P; Winick Naomi J; Camitta Bruce M; Gaynon Paul S; Carroll William L
Reinduction platform for children with first marrow relapse of acute lymphoblastic Leukemia: A Children's Oncology Group Study[corrected].
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(24):3971-8.
-
2008: Trigg Michael E; Sather Harland N; Reaman Gregory H; Tubergen David G; Steinherz Peter G; Gaynon Paul S; Uckun Fatih M; Hammond G Denman;
Ten-year survival of children with acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Leukemia & lymphoma 2008;49(6):1142-54.
-
2008: Harned Theresa M; Gaynon Paul S
Treating refractory leukemias in childhood, role of clofarabine.
Therapeutics and clinical risk management 2008;4(2):327-36.
-
2008: Seibel Nita L; Steinherz Peter G; Sather Harland N; Nachman James B; Delaat Cynthia; Ettinger Lawrence J; Freyer David R; Mattano Leonard A; Hastings Caroline A; Rubin Charles M; Bertolone Kathy; Franklin Janet L; Heerema Nyla A; Mitchell Torrey L; Pyesmany Allan F; La Mei K; Edens Cheryl; Gaynon Paul S
Early postinduction intensification therapy improves survival for children and adolescents with high-risk acute lymphoblastic leukemia: a report from the Children's Oncology Group.
Blood 2008;111(5):2548-55.
-
2007: Malempati Suman; Gaynon Paul S; Sather Harland; La Mei K; Stork Linda C;
Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(36):5800-7.
-
2007: Heerema Nyla A; Raimondi Susana C; Anderson James R; Biegel Jaclyn; Camitta Bruce M; Cooley Linda D; Gaynon Paul S; Hirsch Betsy; Magenis R Ellen; McGavran Loris; Patil Shivanand; Pettenati Mark J; Pullen Jeanette; Rao Kathleen; Roulston Diane; Schneider Nancy R; Shuster Jonathan J; Sanger Warren; Sutcliffe Maxine J; van Tuinen Peter; Watson Michael S; Carroll Andrew J
Specific extra chromosomes occur in a modal number dependent pattern in pediatric acute lymphoblastic leukemia.
Genes, chromosomes & cancer 2007;46(7):684-93.
-
2007: Butturini Anna M; Dorey Frederick J; Lange Beverly J; Henry David W; Gaynon Paul S; Fu Cecilia; Franklin Janet; Siegel Stuart E; Seibel Nita L; Rogers Paul C; Sather Harland; Trigg Michael; Bleyer W Archie; Carroll William L
Obesity and outcome in pediatric acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(15):2063-9.
-
2007: Schultz Kirk R; Pullen D Jeanette; Sather Harland N; Shuster Jonathan J; Devidas Meenakshi; Borowitz Michael J; Carroll Andrew J; Heerema Nyla A; Rubnitz Jeffrey E; Loh Mignon L; Raetz Elizabeth A; Winick Naomi J; Hunger Stephen P; Carroll William L; Gaynon Paul S; Camitta Bruce M
Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children's Cancer Group (CCG).
Blood 2007;109(3):926-35.
-
2006: Matloub Yousif; Lindemulder Susan; Gaynon Paul S; Sather Harland; La Mei; Broxson Emmett; Yanofsky Rochelle; Hutchinson Raymond; Heerema Nyla A; Nachman James; Blake Marilyn; Wells Linda M; Sorrell April D; Masterson Margaret; Kelleher John F; Stork Linda C;
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic leukemia, reported by the Children's Oncology Group.
Blood 2006;108(4):1165-73.
-
2006: Jarrar Mohammad; Gaynon Paul S; Periclou Antonia P; Fu Cecilia; Harris Richard E; Stram Daniel; Altman Arnold; Bostrom Bruce; Breneman John; Steele David; Trigg Michael; Zipf Theodore; Avramis Vassilios I
Asparagine depletion after pegylated E. coli asparaginase treatment and induction outcome in children with acute lymphoblastic leukemia in first bone marrow relapse: a Children's Oncology Group study (CCG-1941).
Pediatric blood & cancer 2006;47(2):141-6.
-
2006: Gaynon Paul S; Harris Richard E; Altman Arnold J; Bostrom Bruce C; Breneman John C; Hawks Ria; Steele David; Zipf Theodore; Stram Daniel O; Villaluna Doodjuen; Trigg Michael E
Bone marrow transplantation versus prolonged intensive chemotherapy for children with acute lymphoblastic leukemia and an initial bone marrow relapse within 12 months of the completion of primary therapy: Children's Oncology Group study CCG-1941.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3150-6.
-
2006: Jeha Sima; Gaynon Paul S; Razzouk Bassem I; Franklin Janet; Kadota Richard; Shen Violet; Luchtman-Jones Lori; Rytting Michael; Bomgaars Lisa R; Rheingold Susan; Ritchey Kim; Albano Edythe; Arceci Robert J; Goldman Stewart; Griffin Timothy; Altman Arnold; Gordon Bruce; Steinherz Laurel; Weitman Steven; Steinherz Peter
Phase II study of clofarabine in pediatric patients with refractory or relapsed acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1917-23.
-
2006: Gaynon Paul S
Treatment adherence and 6-mercaptopurine metabolites.
Pediatric blood & cancer 2006;46(2):120-1.
-
2006: Hahn Theresa; Wall Donna; Camitta Bruce; Davies Stella; Dillon Hildy; Gaynon Paul; Larson Richard A; Parsons Susan; Seidenfeld Jerome; Weisdorf Daniel; McCarthy Philip L
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(1):1-30.
-
2005: Gaynon Paul S
Childhood acute lymphoblastic leukaemia and relapse.
British journal of haematology 2005;131(5):579-87.
-
2005: Whitlock James A; Sather Harland N; Gaynon Paul; Robison Leslie L; Wells Robert J; Trigg Michael; Heerema Nyla A; Bhatia Smita
Clinical characteristics and outcome of children with Down syndrome and acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2005;106(13):4043-9.
-
2005: Hahn Theresa; Wall Donna; Camitta Bruce; Davies Stella; Dillon Hildy; Gaynon Paul; Larson Richard A; Parsons Susan; Seidenfeld Jerome; Weisdorf Daniel; McCarthy Philip L
The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in children: an evidence-based review.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(11):823-61.
-
2005: Berg Stacey L; Blaney Susan M; Devidas Meenakshi; Lampkin Tom A; Murgo Anthony; Bernstein Mark; Billett Amy; Kurtzberg Joanne; Reaman Greg; Gaynon Paul; Whitlock James; Krailo Mark; Harris Michael B;
Phase II study of nelarabine (compound 506U78) in children and young adults with refractory T-cell malignancies: a report from the Children's Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3376-82.
-
2005: Moorman A V; Raimondi S C; Pui C H; Baruchel A; Biondi A; Carroll A J; Forestier E; Gaynon P S; Harbott J; Harms D O; Heerema N; Pieters R; Schrappe M; Silverman L B; Vilmer E; Harrison C J;
No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2005;19(4):557-63.
-
2005: Bassal Mylène; La Mei K; Whitlock James A; Sather Harland N; Heerema Nyla A; Gaynon Paul S; Stork Linda C
Lymphoblast biology and outcome among children with Down syndrome and ALL treated on CCG-1952.
Pediatric blood & cancer 2005;44(1):21-8.
-
2004: Bonate Peter L; Craig Adam; Gaynon Paul; Gandhi Varsha; Jeha Sima; Kadota Richard; Lam Gilbert N; Plunkett William; Razzouk Bassem; Rytting Michael; Steinherz Peter; Weitman Steve
Population pharmacokinetics of clofarabine, a second-generation nucleoside analog, in pediatric patients with acute leukemia.
Journal of clinical pharmacology 2004;44(11):1309-22.
-
2004: Masera Giuseppe; Eden Tim; Schrappe Martin; Nachman James; Gadner Helmut; Gaynon Paul; Evans William E; Pui Ching-Hon;
Statement by members of the Ponte di Legno Group on the right of children to have full access to essential treatment for acute lymphoblastic leukemia.
Pediatric blood & cancer 2004;43(2):103-4.
-
2004: Heerema N A; Nachman J B; Sather H N; La M K; Hutchinson R; Lange B J; Bostrom B; Steinherz P G; Gaynon P S; Uckun F M;
Deletion of 7p or monosomy 7 in pediatric acute lymphoblastic leukemia is an adverse prognostic factor: a report from the Children's Cancer Group.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(5):939-47.
-
2004: Panosyan Eduard H; Seibel Nita L; Martin-Aragon Sagrario; Gaynon Paul S; Avramis Ioannis A; Sather Harland; Franklin Janet; Nachman James; Ettinger Lawrence J; La Mei; Steinherz Peter; Cohen Lewis J; Siegel Stuart E; Avramis Vassilios I;
Asparaginase antibody and asparaginase activity in children with higher-risk acute lymphoblastic leukemia: Children's Cancer Group Study CCG-1961.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2004;26(4):217-26.
-
2004: Heerema N A; Harbott J; Galimberti S; Camitta B M; Gaynon P S; Janka-Schaub G; Kamps W; Basso G; Pui C-H; Schrappe M; Auclerc M-F; Carroll A J; Conter V; Harrison C J; Pullen J; Raimondi S C; Richards S; Riehm H; Sather H N; Shuster J J; Silverman L B; Valsecchi M G; Aricò M;
Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):693-702.
-
2004: Perentesis J P; Bhatia S; Boyle E; Shao Y; Shu X Ou; Steinbuch M; Sather H N; Gaynon P; Kiffmeyer W; Envall-Fox J; Robison L L
RAS oncogene mutations and outcome of therapy for childhood acute lymphoblastic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(4):685-92.
-
2004: Panosyan Eduard H; Grigoryan Rita S; Avramis Ioannis A; Seibel Nita L; Gaynon Paul S; Siegel Stuart E; Fingert Howard J; Avramis Vassilios I
Deamination of glutamine is a prerequisite for optimal asparagine deamination by asparaginases in vivo (CCG-1961).
Anticancer research 2004;24(2C):1121-5.
-
2004: Grigoryan Rita S; Panosyan Eduard H; Seibel Nita L; Gaynon Paul S; Avramis Ioannis A; Avramis Vassilios I
Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961).
In vivo (Athens, Greece) 2004;18(2):107-12.
-
2003: Reid Gregor S D; Terrett Luke; Alessandri Angela J; Grubb Stacey; Stork Linda; Seibel Nita; Gaynon Paul; Schultz Kirk R
Altered patterns of T cell cytokine production induced by relapsed pre-B ALL cells.
Leukemia research 2003;27(12):1135-42.
-
2003: Levy Adam S; Sather Harland N; Steinherz Peter G; Sowers Rebecca; La Mei; Moscow Jeffrey A; Gaynon Paul S; Uckun Fatih M; Bertino Joseph R; Gorlick Richard;
Reduced folate carrier and dihydrofolate reductase expression in acute lymphocytic leukemia may predict outcome: a Children's Cancer Group Study.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(9):688-95.
-
2003: Wu Shi Qi; Weinberg Kenneth I; Joo Wan Jong; Quinn John J; Franklin Janet; Siegel Stuart E; Gaynon Paul S
Preponderant mitotic activity of nonleukemic cells plays an important role in failures to detect abnormal clone in childhood acute lymphoblastic leukemia.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2003;25(7):520-5.
-
2003: Hutchinson Raymond J; Gaynon Paul S; Sather Harland; Bertolone Salvatore J; Cooper Herbert A; Tannous Raymond; Wells Linda M; Heerema Nyla A; Sailer Scott; Trigg Michael E;
Intensification of therapy for children with lower-risk acute lymphoblastic leukemia: long-term follow-up of patients treated on Children's Cancer Group Trial 1881.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(9):1790-7.
-
2003: Bostrom Bruce C; Sensel Martha R; Sather Harland N; Gaynon Paul S; La Mei K; Johnston Katherine; Erdmann Gary R; Gold Stuart; Heerema Nyla A; Hutchinson Raymond J; Provisor Arthur J; Trigg Michael E;
Dexamethasone versus prednisone and daily oral versus weekly intravenous mercaptopurine for patients with standard-risk acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 2003;101(10):3809-17.
-
2002: Bhatia Smita; Sather Harland N; Heerema Nyla A; Trigg Michael E; Gaynon Paul S; Robison Leslie L
Racial and ethnic differences in survival of children with acute lymphoblastic leukemia.
Blood 2002;100(6):1957-64.
-
2002: Gaynon Paul S
Response to Donadieu and Hill "Clinical trials in childhood acute lymphoblastic leukemia: a common prognostic classification and a common induction therapy are now warranted".
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2002;24(6):426-8.
-
2002: Davies Stella M; Bhatia Smita; Ross Julie A; Kiffmeyer William R; Gaynon Paul S; Radloff Gretchen A; Robison Leslie L; Perentesis John P
Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia.
Blood 2002;100(1):67-71.
-
2002: Pui Ching-Hon; Gaynon Paul S; Boyett James M; Chessells Judith M; Baruchel André; Kamps Willem; Silverman Lewis B; Biondi Andrea; Harms Dörthe O; Vilmer Etienne; Schrappe Martin; Camitta Bruce
Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region.
Lancet 2002;359(9321):1909-15.
-
2002: Bhatia Smita; Sather Harland N; Pabustan Olga B; Trigg Michael E; Gaynon Paul S; Robison Leslie L
Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983.
Blood 2002;99(12):4257-64.
-
2002: Kurre Helen A; Ettinger Alice G; Veenstra David L; Gaynon Paul S; Franklin Janet; Sencer Susan F; Reaman Gregory H; Lange Beverly J; Holcenberg John S
A pharmacoeconomic analysis of pegaspargase versus native Escherichia coli L-asparaginase for the treatment of children with standard-risk, acute lymphoblastic leukemia: the Children's Cancer Group study (CCG-1962).
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2002;24(3):175-81.
-
2002: Gaynon Paul S
From where do clinical trials come?
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2002;24(3):172-4.
-
2002: Avramis Vassilios I; Sencer Susan; Periclou Antonia P; Sather Harland; Bostrom Bruce C; Cohen Lewis J; Ettinger Alice G; Ettinger Lawrence J; Franklin Janet; Gaynon Paul S; Hilden Joanne M; Lange Beverly; Majlessipour Fataneh; Mathew Pracad; Needle Michael; Neglia Joseph; Reaman Gregory; Holcenberg John S; Stork Linda
A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 2002;99(6):1986-94.
-
2002: Heerema Nyla A; Sather Harland N; Sensel Martha G; La Mei K L; Hutchinson Raymond J; Nachman James B; Reaman Gregory H; Lange Beverly J; Steinherz Peter G; Bostrom Bruce C; Gaynon Paul S; Uckun Fatih M
Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia.
Cancer 2002;94(4):1102-10.
-
2001: Uckun F M; Pallisgaard N; Hokland P; Navara C; Narla R; Gaynon P S; Sather H; Heerema N
Expression of TEL-AML1 fusion transcripts and response to induction therapy in standard risk acute lymphoblastic leukemia.
Leukemia & lymphoma 2001;42(1-2):41-56.
-
2001: Gaynon P S; Bostrom B C; Hutchinson R J; Lange B J; Nachman J B; Steinherz P G; Sensel M G; Lee M K; Stram D O; Sather H N
Duration of hospitalization as a measure of cost on Children's Cancer Group acute lymphoblastic leukemia studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1916-25.
-
2001: Uckun F M; Gaynon P S; Stram D O; Sensel M G; Sarquis M B; Willoughby M
Bone marrow leukemic progenitor cell content in pediatric T-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Leukemia & lymphoma 2001;40(3-4):279-85.
-
2000: Gaynon P S; Trigg M E; Heerema N A; Sensel M G; Sather H N; Hammond G D; Bleyer W A
Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983-1995.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(12):2223-33.
-
2000: Heerema N A; Sather H N; Sensel M G; Lee M K; Hutchinson R J; Nachman J B; Reaman G H; Lange B J; Steinherz P G; Bostrom B C; Gaynon P S; Uckun F M
Abnormalities of chromosome bands 13q12 to 13q14 in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(22):3837-44.
-
2000: Uckun F M; Stork L; Seibel N; Sarquis M; Bedros C; Sather H; Sensel M; Reaman G H; Gaynon P S
Residual bone marrow leukemic progenitor cell burden after induction chemotherapy in pediatric patients with acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3123-30.
-
2000: Heerema N A; Sather H N; Sensel M G; Zhang T; Hutchinson R J; Nachman J B; Lange B J; Steinherz P G; Bostrom B C; Reaman G H; Gaynon P S; Uckun F M
Prognostic impact of trisomies of chromosomes 10, 17, and 5 among children with acute lymphoblastic leukemia and high hyperdiploidy (> 50 chromosomes).
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(9):1876-87.
-
2000: Heerema N A; Sather H N; Sensel M G; Lee M K; Hutchinson R; Nachman J B; Lange B J; Steinherz P G; Bostrom B; Gaynon P S; Uckun F M
Prognostic significance of cytogenetic abnormalities of chromosome arm 12p in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Cancer 2000;88(8):1945-54.
-
2000: Heerema N A; Sather H N; Sensel M G; Lee M K; Hutchinson R; Lange B J; Bostrom B C; Nachman J B; Steinherz P G; Gaynon P S; Uckun F M
Clinical significance of deletions of chromosome arm 6q in childhood acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 2000;36(5-6):467-78.
-
2000: Trigg M E; Steinherz P G; Chappell R; Johnstone H S; Gaynon P S; Kersey J H; Cherlow J M; Grossman N J; Sather H N; Hammond G D
Early testicular biopsy in males with acute lymphoblastic leukemia: lack of impact on subsequent event-free survival.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 2000;22(1):27-33.
-
1999: Heerema N A; Nachman J B; Sather H N; Sensel M G; Lee M K; Hutchinson R; Lange B J; Steinherz P G; Bostrom B; Gaynon P S; Uckun F
Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group.
Blood 1999;94(12):4036-45.
-
1999: Sun L; Goodman P A; Wood C M; Crotty M L; Sensel M; Sather H; Navara C; Nachman J; Steinherz P G; Gaynon P S; Seibel N; Vassilev A; Juran B D; Reaman G H; Uckun F M
Expression of aberrantly spliced oncogenic ikaros isoforms in childhood acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(12):3753-66.
-
1999: Uckun F M; Gaynon P S; Stram D O; Sensel M G; Sarquis M B; Lazarus K H; Willoughby M
Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(9):2415-20.
-
1999: Heerema N A; Sather H N; Sensel M G; Liu-Mares W; Lange B J; Bostrom B C; Nachman J B; Steinherz P G; Hutchinson R; Gaynon P S; Arthur D C; Uckun F M
Association of chromosome arm 9p abnormalities with adverse risk in childhood acute lymphoblastic leukemia: A report from the Children's Cancer Group.
Blood 1999;94(5):1537-44.
-
1999: Sun L; Crotty M L; Sensel M; Sather H; Navara C; Nachman J; Steinherz P G; Gaynon P S; Seibel N; Mao C; Vassilev A; Reaman G H; Uckun F M
Expression of dominant-negative Ikaros isoforms in T-cell acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(8):2112-20.
-
1999: Uckun F M; Nachman J B; Sather H N; Sensel M G; Kraft P; Steinherz P G; Lange B; Hutchinson R; Reaman G H; Gaynon P S; Heerema N A
Poor treatment outcome of Philadelphia chromosome-positive pediatric acute lymphoblastic leukemia despite intensive chemotherapy.
Leukemia & lymphoma 1999;33(1-2):101-6.
-
1999: Reaman G H; Sposto R; Sensel M G; Lange B J; Feusner J H; Heerema N A; Leonard M; Holmes E J; Sather H N; Pendergrass T W; Johnstone H S; O'Brien R T; Steinherz P G; Zeltzer P M; Gaynon P S; Trigg M E; Uckun F M
Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):445-55.
-
1999: Uckun F M; Waurzyniak B J; Sather H N; Sensel M G; Chelstrom L; Nachman J; Gaynon P S; Bostrom B; Ek O; Sarquis M; Steinherz P G; Reaman G H
Prognostic significance of T-lineage leukemic cell growth in SCID mice: a Children's Cancer Group study.
Leukemia & lymphoma 1999;32(5-6):475-87.
-
1999: Moskowitz I P; Gaynon P S; Shahidi N T; Cripe T P
Low-dose cyclosporin A therapy in children with refractory immune thrombocytopenic purpura.
Journal of pediatric hematology/oncology : official journal of the American Society of Pediatric Hematology/Oncology 1999;21(1):77-9.
-
1998: Waurzyniak B J; Heerema N; Sensel M G; Gaynon P S; Kraft P; Sather H N; Chelstrom L; Reaman G H; Uckun F M
Distinct in vivo engraftment and growth patterns of t(1;19)+/E2A-PBX1+ and t(9;22)+/BCR-ABL+ human leukemia cells in SCID mice.
Leukemia & lymphoma 1998;32(1-2):77-87.
-
1998: Uckun F M; Nachman J B; Sather H N; Sensel M G; Kraft P; Steinherz P G; Lange B; Hutchinson R; Reaman G H; Gaynon P S; Heerema N A
Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group.
Cancer 1998;83(9):2030-9.
-
1998: Ek O; Gaynon P; Zeren T; Chelstrom L M; Myers D E; Uckun F M
Treatment of human B-cell precursor leukemia in SCID mice by using a combination of the anti-CD19 immunotoxin B43-PAP with the standard chemotherapeutic drugs vincristine, methylprednisolone, and L-asparaginase.
Leukemia & lymphoma 1998;31(1-2):143-9.
-
1998: Uckun F M; Sather H N; Waurzyniak B J; Sensel M G; Chelstrom L; Ek O; Sarquis M B; Nachman J; Bostrom B; Reaman G H; Gaynon P S
Prognostic significance of B-lineage leukemic cell growth in SCID mice: a Children's Cancer Group Study.
Leukemia & lymphoma 1998;30(5-6):503-14.
-
1998: Uckun F M; Herman-Hatten K; Crotty M L; Sensel M G; Sather H N; Tuel-Ahlgren L; Sarquis M B; Bostrom B; Nachman J B; Steinherz P G; Gaynon P S; Heerema N
Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation.
Blood 1998;92(3):810-21.
-
1998: Uckun F M; Waurzyniak B J; Sensel M G; Chelstrom L; Crotty M L; Gaynon P S; Reaman G H
Primary blasts from infants with acute lymphoblastic leukemia cause overt leukemia in SCID mice.
Leukemia & lymphoma 1998;30(3-4):269-77.
-
1998: Nachman J B; Sather H N; Sensel M G; Trigg M E; Cherlow J M; Lukens J N; Wolff L; Uckun F M; Gaynon P S
Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy.
The New England journal of medicine 1998;338(23):1663-71.
-
1998: Heerema N A; Sather H N; Sensel M G; Kraft P; Nachman J B; Steinherz P G; Lange B J; Hutchinson R S; Reaman G H; Trigg M E; Arthur D C; Gaynon P S; Uckun F M
Frequency and clinical significance of cytogenetic abnormalities in pediatric T-lineage acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(4):1270-8.
-
1998: Gaynon P S; Qu R P; Chappell R J; Willoughby M L; Tubergen D G; Steinherz P G; Trigg M E
Survival after relapse in childhood acute lymphoblastic leukemia: impact of site and time to first relapse--the Children's Cancer Group Experience.
Cancer 1998;82(7):1387-95.
-
1998: Nachman J; Sather H N; Cherlow J M; Sensel M G; Gaynon P S; Lukens J N; Wolff L; Trigg M E
Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(3):920-30.
-
1998: Uckun F M; Sensel M G; Sather H N; Gaynon P S; Arthur D C; Lange B J; Steinherz P G; Kraft P; Hutchinson R; Nachman J B; Reaman G H; Heerema N A
Clinical significance of translocation t(1;19) in childhood acute lymphoblastic leukemia in the context of contemporary therapies: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(2):527-35.
-
1998: Steinherz P G; Gaynon P S; Breneman J C; Cherlow J M; Grossman N J; Kersey J H; Johnstone H S; Sather H N; Trigg M E; Uckun F M; Bleyer W A
Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: randomized controlled trial from the Children's Cancer Group.
Cancer 1998;82(3):600-12.
-
1998: Uckun F M; Sensel M G; Sun L; Steinherz P G; Trigg M E; Heerema N A; Sather H N; Reaman G H; Gaynon P S
Biology and treatment of childhood T-lineage acute lymphoblastic leukemia.
Blood 1998;91(3):735-46.
-
1997: Uckun F M; Sather H; Gaynon P; Arthur D; Nachman J; Sensel M; Steinherz P; Hutchinson R; Trigg M; Reaman G
Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Leukemia & lymphoma 1997;27(5-6):445-57.
-
1997: Gaynon P S; Desai A A; Bostrom B C; Hutchinson R J; Lange B J; Nachman J B; Reaman G H; Sather H N; Steinherz P G; Trigg M E; Tubergen D G; Uckun F M
Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review.
Cancer 1997;80(9):1717-26.
-
1997: Ettinger L J; Ivy P; Gaynon P S; Ettinger A G; Liu-Mares W; Krailo M D
A phase II study of carboplatin as a treatment for children with acute leukemia recurring in bone marrow: a report of the Children's Cancer Group.
Cancer 1997;80(2):311-6.
-
1997: Uckun F M; Sather H N; Gaynon P S; Arthur D C; Trigg M E; Tubergen D G; Nachman J; Steinherz P G; Sensel M G; Reaman G H
Clinical features and treatment outcome of children with myeloid antigen positive acute lymphoblastic leukemia: a report from the Children's Cancer Group.
Blood 1997;90(1):28-35.
-
1997: Schultz K R; Massing B; Spinelli J J; Gaynon P S; Wadsworth L
Importance of the day 7 bone marrow biopsy as a prognostic measure of the outcome in children with acute lymphoblastic leukemia.
Medical and pediatric oncology 1997;29(1):16-22.
-
1997: Gaynon P S; Crotty M L; Sather H N; Bostrom B C; Nachman J B; Steinherz P G; Heerema N A; Sarquis M; Tuel-Ahlgren L; Uckun F M
Expression of BCR-ABL, E2A-PBX1, and MLL-AF4 fusion transcripts in newly diagnosed children with acute lymphoblastic leukemia: a Children's Cancer Group initiative.
Leukemia & lymphoma 1997;26(1-2):57-65.
-
1997: Nachman J; Sather H N; Gaynon P S; Lukens J N; Wolff L; Trigg M E
Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2222-30.
-
1997: Uckun F M; Gaynon P S; Sensel M G; Nachman J; Trigg M E; Steinherz P G; Hutchinson R; Bostrom B C; Sather H N; Reaman G H
Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: a Children's Cancer Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(6):2214-21.
-
1997: Uckun F M; Yang Z; Sather H; Steinherz P; Nachman J; Bostrom B; Crotty L; Sarquis M; Ek O; Zeren T; Tubergen D; Reaman G; Gaynon P
Cellular expression of antiapoptotic BCL-2 oncoprotein in newly diagnosed childhood acute lymphoblastic leukemia: a Children's Cancer Group Study.
Blood 1997;89(10):3769-77.
-
1997: Uckun F M; Gaynon P; Sather H; Arthur D; Trigg M; Tubergen D; Nachman J; Steinherz P; Sensel M G; Reaman G R
Clinical features and treatment outcome of children with biphenotypic CD2+ CD19+ acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1997;89(7):2488-93.
-
1997: Ettinger L J; Ettinger A G; Avramis V I; Gaynon P S
[In Process Citation]
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 1997;7(1):30-9.
-
1996: Uckun F M; Reaman G; Steinherez P G; Arthur D C; Sather H; Trigg M; Tubergen D; Gaynon P
Improved clinical outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: a Children's Cancer Group Study.
Leukemia & lymphoma 1996;24(1-2):57-70.
-
1996: Uckun F M; Steinherz P G; Sather H; Trigg M; Arthur D; Tubergen D; Gaynon P; Reaman G
CD2 antigen expression on leukemic cells as a predictor of event-free survival after chemotherapy for T-lineage acute lymphoblastic leukemia: a Children's Cancer Group study.
Blood 1996;88(11):4288-95.
-
1996: Cherlow J M; Sather H; Steinherz P; Gaynon P; Tubergen D; Trigg M; Novak L; Bleyer W A
Craniospinal irradiation for acute lymphoblastic leukemia with central nervous system disease at diagnosis: a report from the Children's Cancer Group.
International journal of radiation oncology, biology, physics 1996;36(1):19-27.
-
1996: Steinherz P G; Gaynon P S; Breneman J C; Cherlow J M; Grossman N J; Kersey J H; Johnstone H S; Sather H N; Trigg M E; Chappell R; Hammond D; Bleyer W A
Cytoreduction and prognosis in acute lymphoblastic leukemia--the importance of early marrow response: report from the Childrens Cancer Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(2):389-98.
-
1996: Smith M; Arthur D; Camitta B; Carroll A J; Crist W; Gaynon P; Gelber R; Heerema N; Korn E L; Link M; Murphy S; Pui C H; Pullen J; Reamon G; Sallan S E; Sather H; Shuster J; Simon R; Trigg M; Tubergen D; Uckun F; Ungerleider R
Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(1):18-24.
-
1995: Gaynon P S
Acute leukemia in children.
Current opinion in hematology 1995;2(4):240-6.
-
1995: Uckun F M; Sather H; Reaman G; Shuster J; Land V; Trigg M; Gunther R; Chelstrom L; Bleyer A; Gaynon P
Leukemic cell growth in SCID mice as a predictor of relapse in high-risk B-lineage acute lymphoblastic leukemia.
Blood 1995;85(4):873-8.
-
1994: Ettinger L J; Gaynon P S; Krailo M D; Ru N; Baum E S; Siegel S E; Hammond G D
A phase II study of carboplatin in children with recurrent or progressive solid tumors. A report from the Childrens Cancer Group.
Cancer 1994;73(4):1297-301.
-
1993: Cherlow J M; Steinherz P G; Sather H N; Gaynon P S; Grossman N J; Kersey J H; Johnstone H S; Breneman J C; Trigg M E; Hammond G D
The role of radiation therapy in the treatment of acute lymphoblastic leukemia with lymphomatous presentation: a report from the Childrens Cancer Group.
International journal of radiation oncology, biology, physics 1993;27(5):1001-9.
-
1993: Gaynon P S; Steinherz P G; Bleyer W A; Ablin A R; Albo V C; Finklestein J Z; Grossman N J; Novak L J; Pyesmany A F; Reaman G H
Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1993;11(11):2234-42.
-
1993: Ettinger L J; Krailo M D; Gaynon P S; Hammond G D
A phase I study of carboplatin in children with acute leukemia in bone marrow relapse. A report from the Childrens Cancer Group.
Cancer 1993;72(3):917-22.
-
1993: Nachman J; Sather H N; Buckley J D; Gaynon P S; Steinherz P G; Tubergen D G; Lampkin B C; Hammond G D
Young adults 16-21 years of age at diagnosis entered on Childrens Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols. Results of treatment.
Cancer 1993;71(10 Suppl):3377-85.
-
1991: Zeltzer P M; Epport K; Nelson M D; Huff K; Gaynon P
Prolonged response to carboplatin in an infant with brain stem glioma.
Cancer 1991;67(1):43-7.
-
1991: Gaynon P S; Steinherz P G; Bleyer W A; Finklestein J Z; Miller D R; Reaman G H; Sather H N; Hammond G D
Association of delivered drug dose and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1991;19(4):221-7.
-
1991: Kowal-Vern A; Johnson F L; Trujillo Y; Nachman J; Radhakrishnan J; Conard P; Gaynon P
Granulocytic sarcoma of the ileum treated by bone marrow transplantation.
The American journal of pediatric hematology/oncology 1991;13(1):34-8.
-
1990: Gaynon P S; Ettinger L J; Baum E S; Siegel S E; Krailo M D; Hammond G D
Carboplatin in childhood brain tumors. A Children's Cancer Study Group Phase II trial.
Cancer 1990;66(12):2465-9.
-
1990: Gaynon P S
Primary treatment of childhood acute lymphoblastic leukemia of non-T cell lineage (including infants).
Hematology/oncology clinics of North America 1990;4(5):915-36.
-
1990: Gaynon P S; Bleyer W A; Steinherz P G; Finklestein J Z; Littman P; Miller D R; Reaman G; Sather H; Hammond G D
Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features.
Medical and pediatric oncology 1990;18(4):273-9.
-
1988: Gaynon P S; Steinherz P G; Bleyer W A; Ablin A R; Albo V C; Finklestein J Z; Grossman N J; Littman P S; Novak L T; Pyesmany A F
Intensive therapy for children with acute lymphoblastic leukaemia and unfavourable presenting features. Early conclusions of study CCG-106 by the Childrens Cancer Study Group.
Lancet 1988;2(8617):921-4.
-
1988: Maurer H S; Steinherz P G; Gaynon P S; Finklestein J Z; Sather H N; Reaman G H; Bleyer W A; Hammond G D
The effect of initial management of hyperleukocytosis on early complications and outcome of children with acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(9):1425-32.
-
1988: Gaynon P S; Bleyer W A; Steinherz P G; Finklestein J Z; Littman P S; Miller D R; Reaman G H; Sather H N; Hammond G D
Modified BFM therapy for children with previously untreated acute lymphoblastic leukemia and unfavorable prognostic features. Report of Children's Cancer Study Group Study CCG-193P.
The American journal of pediatric hematology/oncology 1988;10(1):42-50.
-
1987: Gaynon P S; Ettinger L J; Moel D; Siegel S E; Baum E S; Krivit W; Hammond G D
Pediatric phase I trial of carboplatin: a Childrens Cancer Study Group report.
Cancer treatment reports 1987;71(11):1039-42.
-
1987: Reaman G H; Steinherz P G; Gaynon P S; Bleyer W A; Finklestein J Z; Evans R; Miller D R; Sather H N; Hammond G D
Improved survival of infants less than 1 year of age with acute lymphoblastic leukemia treated with intensive multiagent chemotherapy.
Cancer treatment reports 1987;71(11):1033-8.
-
1987: Gaynon P S; Baum E S; Samsel C; Sather H
Microcomputer-assisted data management for multiinstitutional pediatric clinical cancer trials.
The American journal of pediatric hematology/oncology 1987;9(1):33-41.
-
1986: Steinherz P G; Gaynon P; Miller D R; Reaman G; Bleyer A; Finklestein J; Evans R G; Meyers P; Steinherz L J; Sather H
Improved disease-free survival of children with acute lymphoblastic leukemia at high risk for early relapse with the New York regimen--a new intensive therapy protocol: a report from the Childrens Cancer Study Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1986;4(5):744-52.
-
1982: Gaynon P S; Baum E S; Krivit W; Hammond D
Phase II trial of prednimustine in children with recurrent cancer: a Children's Cancer Study Group report.
Cancer treatment reports 1982;66(7):1583-4.
-
1981: Baum E S; Gaynon P; Greenberg L; Krivit W; Hammond D
Phase II trail cisplatin in refractory childhood cancer: Children's Cancer Study Group Report.
Cancer treatment reports 1981;65(9-10):815-22.
Sign-in to see more
